232 Chapter 10 92. Turnidge JD, Nimmo GR, Pearson J, Gottlieb T, Collignon PJ; Australian Group on Antimicrobial Resistance. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep. 2007;31(4):398-403. 93. van Hal SJ, Jones M, Gosbell IB, Paterson DL. Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections. PLoS One. 2011;6(6): e21217. 94. Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46(6):799-806. 95. Wang JT, Hsu LY, Lauderdale TL, Fan WC, Wang FD. Comparison of outcomes among adult patients with nosocomial bacteremia caused by methicillin-susceptible and methicillin-resistant Staphylococcus aureus: a retrospective cohort study. PLoS One. 2015;10(12):e0144710. 96. Wang JT, Wu HS, Weng CM, Hsu LY, Wang FD. Prognosis of patients with methicillinresistant Staphylococcus aureus bloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations. BMC Infect Dis. 2013;13:182. 97. Wi YM, Rhee JY, Kang CI, Chung DR, Song JH, Peck KR. Clinical predictors of methicillinresistance and their impact on mortality associated with Staphylococcus aureus bacteraemia. Epidemiol Infect. 2018;146(10):1326-1336. 98. Willekens R, Puig-Asensio M, Suanzes P, et al. Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study. J Infect. 2021;83(6): 656-663. 99. Yahav D, Schlesinger A, Shaked H, et al. Clinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults. Aging Clin Exp Res. 2017;29(2):127-133. 100. Yilmaz M, Elaldi N, Balkan, et al. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann Clin Microbiol Antimicrob. 2016;15(1):7. 101. Yoon YK, Park DW, Sohn JW, et al. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infect Dis. 2016;16:331. 102. Westgeest AC, Buis DTP, Sigaloff KCE, Ruffin F, et al. Global differences in the management of Staphylococcus aureus bacteremia: no international standard of care. Clin Infect Dis. 2023;77(8):1092-1101. 103. Leibovici L, Paul M, Weinberger M, et al. Excess mortality in women with hospital-acquired bloodstream infection. Am J Med. 2001;111(2):120-125. 104. Sakr Y, Elia C, Mascia L, et al. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care. 2013;17(2):R50. 105. Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med. 2010;7(5):422-437. 106. Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-353. 107. Varela Barca L, Vidal-Bonnet L, Fariñas MC, et al; GAMES Investigators. Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain. Heart. 2021;107(21):1717-1724.
RkJQdWJsaXNoZXIy MTk4NDMw